aflatoxin b1 has been researched along with Cirrhosis, Liver in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| D'Errico, A; Fornari, F; Giovannini, C; Gnudi, F; Gramantieri, L; Mandrioli, D; Piscaglia, F; Suzzi, F; Tovoli, F; Vasuri, F; Vornoli, A | 1 |
| Gao, GC; Gao, JL; Li, C; Lin, QY; Liu, SH; Ru, YJ; Wang, L; Wu, JM; Yang, YD; Zhang, XQ; Zheng, CW; Zheng, YX | 1 |
| Abd El Baky, HE; Abd Elkader, HM; El Dessouki, N; El Tagy, G; ElHaddad, AA; Esmat, H; Hashim, M; Kaddah, S; Kotb, A; Kotb, HA; Kotb, MA; Lotfi, N; Shehata, S; Shehata, SM; Talaat, S; Zekry, H | 1 |
| Li, LQ; Ma, L; Qi, LN; Qin, HG; Wang, YY; Xiang, BD; Xiang, X; You, XM; Zhong, JH | 1 |
| Nault, JC | 1 |
| El-Serag, HB | 1 |
| Bah, E; Chemin, I; Ferro, G; Friesen, MD; Gouas, DA; Groopman, J; Hainaut, P; Kirk, GD; Legros, P; Lesi, OA; Mendy, M; Ortiz-Cuaran, S; Villar, S | 1 |
| Chen, CJ; Santella, RM; Sun, CA; Wang, LY; Wu, DM; You, SL | 1 |
| Cecere, A; Gattoni, A; Marotta, F; Vangieri, B | 1 |
| Abdel-Hadi, AA; Abu Zikri, NB; El-Ansary, M; El-Raai, A; El-Shanawani, FM; Ismail, A | 1 |
| Bhandari, B; Bhandari, PC | 1 |
| Blum, HE; Moradpour, D | 1 |
| Mo, CC; Yeh, FS; Yen, RC | 1 |
3 review(s) available for aflatoxin b1 and Cirrhosis, Liver
| Article | Year |
|---|---|
Pathogenesis of hepatocellular carcinoma according to aetiology.
Topics: Aflatoxin B1; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis C; Humans; Liver Cirrhosis; Liver Neoplasms; Mutagenesis, Insertional; Point Mutation; Risk Factors; Tumor Suppressor Protein p53 | 2014 |
Epidemiology of viral hepatitis and hepatocellular carcinoma.
Topics: Aflatoxin B1; Biomarkers; Carcinoma, Hepatocellular; Coinfection; Cost of Illness; DNA, Viral; Epidemiologic Studies; Genotype; Global Health; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Incidence; Liver Cirrhosis; Liver Neoplasms; Meta-Analysis as Topic; Prevalence; Risk Assessment; Risk Factors; United States; Virus Replication | 2012 |
The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Topics: Aflatoxin B1; Animals; Carcinoma, Hepatocellular; Controlled Clinical Trials as Topic; Gene Expression; Genes, p53; Genetic Therapy; Hepatectomy; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Immunotherapy; Immunotherapy, Active; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Liver Regeneration; Mice; Mice, Transgenic; Multicenter Studies as Topic; Mutation; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; T-Lymphocytes, Cytotoxic; Transforming Growth Factor beta | 2004 |
10 other study(ies) available for aflatoxin b1 and Cirrhosis, Liver
| Article | Year |
|---|---|
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area.
Topics: Aflatoxin B1; Animals; Carcinoma, Hepatocellular; Cholangiocarcinoma; DNA Adducts; Liver Cirrhosis; Liver Neoplasms; Rats | 2022 |
Schisantherin D from Schisandra chinensis (Turcz.) Baill. exhibits anti-liver fibrosis capacity via modulating ETBR involved signaling, an in vitro and in vivo study.
Topics: Acetaminophen; Aflatoxin B1; Animals; Dioxoles; Humans; Lignans; Liver Cirrhosis; Mice; Molecular Structure; NF-E2-Related Factor 2; Receptor, Endothelin B; Schisandra; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2022 |
Congenital aflatoxicosis, mal-detoxification genomics & ontogeny trigger immune-mediated Kotb disease biliary atresia variant: SANRA compliant review.
Topics: Aflatoxin B1; Biliary Atresia; Child; Genomics; Glutathione Transferase; Humans; Immune System Diseases; Infant, Newborn; Liver; Liver Cirrhosis; Pancreatic Elastase; Tumor Suppressor Protein p53 | 2022 |
Expression of P62 in hepatocellular carcinoma involving hepatitis B virus infection and aflatoxin B1 exposure.
Topics: Adult; Aflatoxin B1; Biomarkers; Carcinoma, Hepatocellular; Cell Line, Tumor; Female; Follow-Up Studies; Gene Expression; Hepatitis B; Hepatitis B virus; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Neovascularization, Pathologic; NF-E2-Related Factor 2; Prognosis; RNA-Binding Proteins; RNA, Messenger; Signal Transduction; Survival Analysis; Tumor Burden | 2017 |
TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia.
Topics: Adult; Aflatoxin B1; Carcinoma, Hepatocellular; Case-Control Studies; Female; Gambia; Genes, p53; Genetic Variation; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Polymorphism, Single Nucleotide; Risk Factors; Trans-Activators; Tumor Suppressor Protein p53; Viral Regulatory and Accessory Proteins | 2012 |
Determinants of formation of aflatoxin-albumin adducts: a seven-township study in Taiwan.
Topics: Adult; Aflatoxin B1; Aflatoxins; Albumins; Carcinoma, Hepatocellular; Case-Control Studies; Cross-Sectional Studies; Environmental Exposure; Enzyme-Linked Immunosorbent Assay; Female; Glutathione Transferase; Hepatitis B Surface Antigens; Hepatitis C Antibodies; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Taiwan | 2002 |
Clinical significance of aflatoxin, mutant P53 gene and sIL-2 receptor in liver cirrhosis and hepatocellular carcinoma.
Topics: Aflatoxin B1; Carcinoma, Hepatocellular; DNA Mutational Analysis; Female; Genes, p53; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Mutation; Receptors, Interleukin-2; Risk Factors | 2006 |
Aflatoxin and Indian Childhood Cirrhosis.
Topics: Aflatoxin B1; Aflatoxins; Child, Preschool; Humans; India; Infant; Infant, Newborn; Liver Cirrhosis | 1980 |
[Molecular aspects of hepatocellular carcinoma].
Topics: Adult; Aflatoxin B1; Age Factors; Alcoholism; Animals; Carcinoma, Hepatocellular; Child; Cohort Studies; DNA; DNA Repair; Enzyme Activation; Genes, p53; Growth Substances; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Marmota; Mice; Mice, Transgenic; Middle Aged; Mutation; Risk Factors; Telomerase | 2000 |
Risk factors for hepatocellular carcinoma in Guangxi, People's Republic of China.
Topics: Aflatoxin B1; Aflatoxins; Carcinoma, Hepatocellular; China; Food Contamination; Hepatitis B; Hepatitis B Surface Antigens; Humans; Liver Cirrhosis; Liver Neoplasms; Risk | 1985 |